Take part in the pros and cons sessions happening inthe hepatology arena in hall C.
|Thursday 11 April||NASH does not alter a patient’s natural history – only fibrosis does||12:00-13:00|
|Friday 12 April||Issues in the radiological evaluation of advanced hepatocelullar carcinoma||14:00-15:00|
|Friday 12 April||Patients with immuntolerant HBeAg positive infection should/should not be treated||15:00-16:00|
|Saturday 13 April||Prolonged antibiotic prophylaxis in patients with cirrhosis is harmful?||14:00-15:00|
|Sunday 14 April||PBC patients with inadequate response to UDCA: obeticholic acid or bezafibrate?||10:30-11:30|